In contrast, mutations in the middle part of FBN1 (exons 25 to 33) are recognized as associated with neonatal MS, which is characterized by severe mitral and/or tricuspid valvular insufficiency and pulmonary emphysema. Here, FBN1 is linked to myeloid sarcoma.